The report “Global Proton Therapy Market Outlook 2021”
provides an in-depth analysis of global proton therapy treatment market with
focus on major regional market such as North America, Europe and Asia Pacific.
North America is the world’s largest proton therapy market with high
predominance in the US. In Europe, Germany and the UK are major markets. The
proton therapy systems market has been segmented into pencil beam scanning
systems, uniform scanning systems and passive scattering systems on the basis
of type of system. Out of these, pencil beam scanning being most precise form
of proton therapy enjoys highest popularity.
Growth of the global proton therapy industry is driven by
rise in cancer incidences, especially prostate cancer. Rising prevalence of
chronic diseases in ageing population globally; and minimal invasiveness
associated with use of proton therapy. However, major industry restraints
include stringent regulations, high installation costs and reimbursement being
limited to few uncommon cancer types. Global proton therapy industry is highly
consolidated with three major players – IBA Proton Therapy Inc, Varian Medical
Systems and Hitachi Limited dominating the market. These players have been
profiled in the report.
Market Segmentation by Region
- North America
- The US
- Asia Pacific
- Europe
Key Vendors
- IBA Proton Therapy Inc
- Varian Medical Systems
- Hitachi Ltd
Spanning over 62 pages, 13 Tables and 42
Figures “Global
Proton Therapy Market Outlook 2021” report covers Executive Summary, Research
Methodology, Proton Therapy, Proton Therapy Market Analysis, Global Proton
Therapy Market: Regional Analysis, Proton Therapy Market Dynamics, Competitive
Landscape, Company Profiles. This report Covered Companies - IBA Proton Therapy
Inc, Hitachi Ltd, Varian Medical Systems.
For
more information Visit at: http://mrr.cm/3CG
Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.